Found: 5
Select item for more details and to access through your institution.
Pharmacokinetic profile of Optivate<sup>®</sup> (high-purity factor VIII/von Willebrand factor concentrate) in treating von Willebrand disease.
- Published in:
- Haemophilia, 2016, v. 22, n. 1, p. e64, doi. 10.1111/hae.12843
- By:
- Publication type:
- Article
Clinical experience with Optivate<sup>®</sup>, high-purity factor VIII (FVIII) product with von Willebrand factor (VWF) in young children with haemophilia A.
- Published in:
- Haemophilia, 2011, v. 17, n. 5, p. 737, doi. 10.1111/j.1365-2516.2011.02600.x
- By:
- Publication type:
- Article
Experience with Optivate.
- Published in:
- Haemophilia, 2011, v. 17, n. 3, p. 428, doi. 10.1111/j.1365-2516.2010.02441.x
- By:
- Publication type:
- Article
Clinical assessment of Optivate.
- Published in:
- Haemophilia, 2011, v. 17, n. 3, p. 456, doi. 10.1111/j.1365-2516.2010.02446.x
- By:
- Publication type:
- Article
Pharmacokinetics of Optivate.
- Published in:
- Haemophilia, 2011, v. 17, n. 2, p. 185, doi. 10.1111/j.1365-2516.2010.02414.x
- By:
- Publication type:
- Article